Alzamend Historical Cash Flow
| ALZN Stock | USD 0.89 0.21 30.88% |
Analysis of Alzamend Neuro cash flow over time is an excellent tool to project Alzamend Neuro future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 177.8 K or Change To Operating Activities of 775.3 K as it is a great indicator of Alzamend Neuro ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Alzamend Neuro latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Alzamend Neuro is a good buy for the upcoming year.
Alzamend |
About Alzamend Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Alzamend balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Alzamend's non-liquid assets can be easily converted into cash.
Alzamend Neuro Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Most accounts from Alzamend Neuro's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Alzamend Neuro current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.At this time, Alzamend Neuro's Issuance Of Capital Stock is very stable compared to the past year.
| 2022 | 2023 | 2024 | 2025 (projected) | Other Non Cash Items | 1.7M | 714.0 | 642.6 | 610.47 | Depreciation | 23.1K | 50.7K | 58.4K | 38.2K |
Alzamend Neuro cash flow statement Correlations
Click cells to compare fundamentals
Alzamend Neuro Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alzamend Neuro cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 1.8M | 12.1M | (8.9M) | (4.8M) | (4.3M) | (4.1M) | |
| Net Borrowings | 72.7K | (16.7K) | 2.3M | (58.7K) | (67.5K) | (64.1K) | |
| Total Cashflows From Investing Activities | 234.1K | 105K | 100.9K | (106.5K) | (122.4K) | (128.5K) | |
| Other Cashflows From Financing Activities | 4.0M | 18.9M | 200.0 | 2.1M | 2.4M | 3.9M | |
| Total Cash From Operating Activities | (2.7M) | (6.6M) | (8.9M) | (8.3M) | (7.4M) | (7.1M) | |
| Change To Operating Activities | (124.3K) | 260.8K | 633.6K | 642.1K | 738.4K | 775.3K | |
| Net Income | (5.0M) | (12.4M) | (14.9M) | (9.9M) | (9.0M) | (9.4M) | |
| Total Cash From Financing Activities | 4.5M | 18.9M | 200.0 | 3.7M | 4.2M | 4.7M | |
| Other Cashflows From Investing Activities | 234.1K | 105K | 100.9K | (5.4M) | (4.8M) | (4.6M) | |
| Change To Netincome | 2.4M | 2.5M | 4.4M | 3.6M | 4.1M | 2.5M | |
| Change To Liabilities | (175.0K) | (413.2K) | 693.6K | 1.7M | 2.0M | 2.1M | |
| End Period Cash Flow | 1.9M | 14.1M | 5.1M | 376.0K | 432.5K | 410.8K | |
| Investments | 105K | 100.9K | (106.5K) | (147.2K) | (132.5K) | (125.9K) | |
| Stock Based Compensation | 2.0M | 4.4M | 3.6M | 955.6K | 1.1M | 1.0M | |
| Free Cash Flow | (2.7M) | (6.7M) | (8.9M) | (8.4M) | (7.6M) | (8.0M) | |
| Change In Working Capital | (152.5K) | 1.3M | 2.3M | 670.7K | 771.3K | 939.6K | |
| Begin Period Cash Flow | 90.3K | 1.9M | 14.1M | 5.1M | 5.9M | 4.0M | |
| Other Non Cash Items | 454.6K | 8.8K | 1.7M | 714.0 | 642.6 | 610.47 | |
| Issuance Of Capital Stock | 2.1M | 18.9M | 4M | 3.4M | 3.9M | 5.7M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alzamend Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.